Molecular alterations: Somatic mutations in KRAS and GNAS are the two most common genetic alterations seen in IPMN, together seen in >95% of all IPMNs [37,38]. The gene discussed is GNAS; the disease is pancreatic intraductal papillary-mucinous neoplasm.